| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF3626-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF3625-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | 3625-IL-010/CF | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB36253-SP | |||
| Carrier Free | IC36253V-100UG | |||
| Carrier Free | IC36253U-100UG | |||
| Carrier Free | IC36253T-100UG | |||
| Carrier Free | IC36253S-100UG | |||
| Carrier Free | IC36253R-100UG | |||
| Carrier Free | IC36253N-100UG | |||
| Carrier Free | IC36253G-100UG | |||
| Carrier Free | IC36253P-100 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-76394-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-27333SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB36252-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB36254-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35248-1mg | |||
| Carrier-Free | NBP2-35248-100ug | |||
| Carrier-Free | NBP2-35248-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF5010-SP | |||
![Western Blot: IL-33 Antibody [NBP1-76394] - Loading: 15ug of human lung lysate. Antibodies: IL-33, 2 g/mL , 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.](http://images.novusbio.com/fullsize/IL-33-Antibody-Western-Blot-NBP1-76394-img0011.jpg "Western Blot: IL-33 Antibody [NBP1-76394] - Loading: 15ug of human lung lysate. Antibodies: IL-33, 2 g/mL , 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.")
![Immunohistochemistry-Paraffin: IL-33 Antibody [NBP1-76394] - Analysis of of IL-33 in human lymph node tissue with IL-33 antibody at 2.5 ug/ml.](http://images.novusbio.com/fullsize/IL-33-Antibody-Immunohistochemistry-Paraffin-NBP1-76394-img0004.jpg)
![Western Blot: IL-33 Antibody [NBP1-76394] - Analysis of IL-33 in A-20 cell lysate with IL-33 antibody at (A) 1 and (B) 2 ug/mL.](http://images.novusbio.com/fullsize/IL-33-Antibody-Western-Blot-NBP1-76394-img0006.jpg)
![Western Blot: IL-33 Antibody [NBP1-76394] - 15. ug of human lung lysate Antibodies: IL-33, NBP1-76394, 2 ug/mL, 1h incubation at RT in 5% NFDM/TBST. Secondary: Goat anti-rabbit IgG HRP conjugate.](http://images.novusbio.com/fullsize/IL-33-Antibody-Western-Blot-NBP1-76394-img0007.jpg)
![Western Blot: IL-33 Antibody [NBP1-76394] - Loading: 5ng (1) and 25ng (2) of IL-33 partial human recombinant protein.Antibodies: IL-33, NBP1-76394, 1 ug/mL , 1h incubation at RT in 5% NFDM/TBST.Secondary: Goat anti-rabbit IgG HRP conjugate at 1:10000 dilution.Il-33 partial human recombinant protein: 112-270aa, 17.9kD, 36kD band is the dimer.](http://images.novusbio.com/fullsize/IL-33-Antibody-Western-Blot-NBP1-76394-img0008.jpg)
![Western Blot: IL-33 Antibody [NBP1-76394] - Regulated Expression Validation of IL-33 in Human Skin Fibroblastsexpression of IL-33 in human skin fibroblasts following alpha-irradiation were detected by anti-IL-33 antibodies. IL-33 levels were increased after Alpha-irradiation, which were inhibited by treatment of PPP.](http://images.novusbio.com/fullsize/IL-33-Antibody-Western-Blot-NBP1-76394-img0009.jpg)
![Western Blot: IL-33 Antibody [NBP1-76394] - Human IL-33 has 4 isoforms, including isoform 1 (270aa, 30.8kD), isoform 2 (228aa, 25.9kD), isoform 3 (228aa, 26.1kD) and isoform 4 (144aa, 16.3kD). This antibody detects only human isoform L. Mouse IL-33 has 1 isoform (266aa, 30kD). Rat IL-33 has only one isoform identified so far (264aa, 29.5kD).](http://images.novusbio.com/fullsize/IL-33-Antibody-Western-Blot-NBP1-76394-img0010.jpg)
![Immunohistochemistry: IL-33 Antibody [NBP1-76394] - Human Lymph Node tissue with IL-33 antibody at 20 ug/mL.](http://images.novusbio.com/fullsize/IL-33-Antibody-Immunofluorescence-NBP1-76394-img0003.jpg)
![Western Blot: IL-33 Antibody (6H617) [NBP2-27333] - Analysis of IL-33 using IL-33 monoclonal antibodyin A) HUVEC cell lysate at 10 ug/mL and B) partial recombinant IL-33 (amino acids 112-270) at 1 ug/mL. Goat anti-mouse Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.](http://images.novusbio.com/fullsize/IL-33-Antibody-6H617-Western-Blot-NBP2-27333-img0004.jpg "Western Blot: IL-33 Antibody (6H617) [NBP2-27333] - Analysis of IL-33 using IL-33 monoclonal antibodyin A) HUVEC cell lysate at 10 ug/mL and B) partial recombinant IL-33 (amino acids 112-270) at 1 ug/mL. Goat anti-mouse Ig HRP secondary antibody and PicoTect ECL substrate solution were used for this test.")
![Flow Cytometry: IL-33 Antibody (6H617) [NBP2-27333] - An intracellular stain was performed on Jurkat cells with IL-33 (6H617) antibody NBP2-27333PE (blue) and a matched isotype control (orange). Cells were fixed with 4% PFA and then permeablized with 0.1% saponin. Cells were incubated in an antibody dilution of 2.5 ug/mL for 30 minutes at room temperature. Both antibodies were conjugated to Phycoerythrin.](http://images.novusbio.com/fullsize/IL-33-Antibody-6H617-Flow-Cytometry-NBP2-27333-img0006.jpg)
![Flow Cytometry: IL-33 Antibody (6H617) [NBP2-27333] - Analysis of IL-33. Jurkat cells (0.5 x 10^6) were intracellularly stained with 0.25 ug of mouse IgG1 isotype control (green) or purified IL-33 antibody (Clone 6H617; red). This antibody and an anti-mouse IgG PE conjugated secondary antibody were used.](http://images.novusbio.com/fullsize/IL-33-Antibody-6H617-Flow-Cytometry-NBP2-27333-img0003.jpg)
![Flow Cytometry: IL-33 Antibody (6H617) [NBP2-27333] - An intracellular stain was performed on Jurkat cells with IL-33 [6H617] Antibody NBP2-27333F (blue) and a matched isotype control (orange). Cells were fixed with 4% PFA and then permeabilized with 0.1% saponin. Cells were incubated in an antibody dilution of 5 ug/mL for 30 minutes at room temperature. Both antibodies were conjugated to FITC.](http://images.novusbio.com/fullsize/IL-33-Antibody-6H617-Flow-Cytometry-NBP2-27333-img0005.jpg)
![SDS-Page: Recombinant Rat IL-33 Protein [NBP2-35248]](http://images.novusbio.com/fullsize/Recombinant-Rat-IL-33-Protein-SDS-Page-NBP2-35248-img0002.jpg "SDS-Page: Recombinant Rat IL-33 Protein [NBP2-35248]")
![Western Blot: IL-33 Antibody [NBP2-24858] - Analysis of IL-33 using IL-33 polyclonal antibody. HUVEC cell lysate probed with IL-33 antibody at 1 ug/ml in the 1) absence and 2) presence of immunizing peptide.](http://images.novusbio.com/fullsize/IL-33-Antibody-Western-Blot-NBP2-24858-img0003.jpg "Western Blot: IL-33 Antibody [NBP2-24858] - Analysis of IL-33 using IL-33 polyclonal antibody. HUVEC cell lysate probed with IL-33 antibody at 1 ug/ml in the 1) absence and 2) presence of immunizing peptide.")
![Simple Western: IL-33 Antibody [NBP2-24858] - Lane view shows a specific band for IL-33 in 0.05 mg/ml of Jurkat lysate. This experiment was performed under reducing conditions using the 12-230 kDa separation system.](http://images.novusbio.com/fullsize/IL-33-Antibody-Simple-Western-NBP2-24858-img0002.jpg)
